Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE begins erythropoietin consultation

  • Comment
NICE has issued a consultation document on the use of erythropoietin for the treatment of cancer-related anaemia.

NICE has issued a consultation document on the use of erythropoietin for the treatment of cancer-related anaemia.

The document proposes that erythropoietin should only be used in severe cases, although patients already being treated with the drug should be allowed to continue.

In the future, the drug should only be used as part of clinical trials to determine future treatment methods for the condition, the document says.

NICE

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.